Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

WHO Warns of Counterfeit Ozempic in the Global Supply Chain—Here’s What to Know | Synapse

July 19, 2024

WHO Warns of Counterfeit Ozempic in the Global Supply Chain—Here’s What to Know

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This Medical News article discusses reports of falsified semaglutide being found around the world.

Me gusta

Guardar

Compartir

Cite This Study

Kate Ruder (Fri,) studied this question.

synapsesocial.com/papers/68e5fb6fb6db64358758f051 https://doi.org/https://doi.org/10.1001/jama.2024.13507

Me gusta

Guardar

Compartir

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Navigating Compounded Semaglutide: What Health Care Providers Need to Know2025 · 1 citations
2Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance2026
38752 The Ethical Concerns Of Improper Semaglutide Administration After Acquisition From A Compounded Pharmacy2024 · 3 citations
4Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases2024 · 36 citations
5The craze with semaglutide2024 · 1 citations